GREY:NPCUF - Post by User
Comment by
your_solution1on Nov 27, 2012 11:45pm
153 Views
Post# 20652535
RE: value of company ??? with FDA approval
RE: value of company ??? with FDA approval my calculation is based on the outstanding shares of 140 mill. and market cap. of now $ 70 Mill. the annual demand on drugs is $ 700 Mill.for the PSP patients. I think it could go 10 fold and keep climbing on the long term.
Then the following hope it could work also for alzheimers (ok it's probably another year away to complete the clinical tests).. this could be a blockbuster biotech...